Vera Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gary Barrera, with a market cap of $2.9B.
Common questions about Vera Therapeutics
Vera Therapeutics is scheduled to report earnings for Q1 2026 on May 5, 2026 before market open. Analysts estimate revenue of $426.0K.
Vera Therapeutics has approximately 55 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.